Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: AstraZeneca CFO makes $1.5m sale, IHG chair buys in

(Sharecast News) - At the top of the list of FTSE 350 director sells on Tuesday was AstraZeneca, whose chief financial officer sold almost $1.5m worth of the company's American depositary shares. The pharmaceuticals giant said Aradhana Sarin sold 19,470 of the shares on 5 May, at a price of $74.81 each.

That valued the transaction at a total of $1,456,550.70.

Two of AstraZeneca's American depositary shares are equivalent to one of its ordinary shares, the firm said in its disclosure.

On the buying side of things, the non-executive chair of InterContinental Hotels Group was also dealing in American depositary instruments, spending almost $0.35m.

The owner of brands including Holiday Inn said Deanna Oppenheimer acquired 5,000 of its American depositary receipts on the New York Stock Exchange on 8 May.

Oppenheimer paid $68.89 for each ADR, valuing the purchase at $344,450 in total.

At 1437 BST, shares in AstraZeneca were up 0.11% in London at 11,884p, while those in InterContinental Hotels Group were 0.6% firmer at 5,442p.

Reporting by Josh White for Sharecast.com.

DIRECTOR SELLS

Company: AstraZeneca Name: Aradhana Sarin Volume: 19,470 Price: $74.81 Value: $1,456,550.70

Company: London Stock Exchange Group Name: York Holdings II Volume: 9,048 Price: 8,359.77p Value: £756,391.99

DIRECTOR BUYS

Company: InterContinental Hotels Group Name: Deanna Oppenheimer Volume: 5,000 Price: $68.89 Value: $344,450.00

Company: CRH Name: Christina Verchere Volume: 1,000 Price: 3,824.4p Value: £38,244.00

Company: Videndum Name: Andrea Rigamonti Volume: 3,500 Price: 789.86p Value: £27,645.07

Company: InterContinental Hotels Group Name: Graham Allan Volume: 300 Price: 5,418.36p Value: £16,255.09

Company: Marshalls Name: Martyn Coffey Volume: 10,000 Price: 156p Value: £15,600.00

Company: InterContinental Hotels Group Name: Duriya Farooqui Volume: 200 Price: $68.625 Value: $13,725.00

Company: InterContinental Hotels Group Name: Daniela Barone Soares Volume: 150 Price: 5,427.55p Value: £8,141.33

Company: Marshalls Name: Alison Lockwood Volume: 3,763 Price: 164p Value: £6,171.32

Company: Marshalls Name: Amanda Bourne Volume: 1,062 Price: 280p Value: £2,973.60

Company: CMC Markets Name: Euan William Marshall Volume: 164 Price: 181.99p Value: £298.46

Company: CMC Markets Name: David John Fineberg Volume: 164 Price: 181.99p Value: £298.46

Company: Moneysupermarket.com Group Name: Matthew Cresswell Volume: 56 Price: 267.3p Value: £149.69

Company: Moneysupermarket.com Group Name: Peter Duffy Volume: 56 Price: 267.3p Value: £149.69

Company: Moneysupermarket.com Group Name: Matthew Whittle Volume: 38 Price: 267.3p Value: £101.57

Share this article

Related Sharecast Articles

Director dealings: Whitbread chairwoman makes share purchase
(Sharecast News) - Whitbread revealed on Tuesday that chairwoman Christine Hodgson had acquired 7,750 ordinary shares in the FTSE 100-listed hotel and restaurant company.
Director dealings: NWF Group chair raises stake
(Sharecast News) - NWF Group revealed on Monday that chairwoman Amanda Burton had acquired 18,470 ordinary shares in the AIM-listed agricultural and distribution business.
Director dealings: PCA of Sage's John Bates snaps up shares
(Sharecast News) - Sage Group revealed on Friday that non-executive director Jillian Bates, a person closely associated with non-executive director John Bates, had acquired 35,000 ordinary shares in the FTSE 100-listed software company.
Director dealings: Yougov non-executive director raises stake
(Sharecast News) - Yougov revealed on Thursday that non-executive director Ashley Martin had acquired 16,586 ordinary shares in the AIM-listed market research and data analytics firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.